Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121444535 | 12144453 | 5 | F | 2015 | 20160920 | 20160304 | 20160930 | PER | US-PFIZER INC-2016118203 | PFIZER | 72.00 | YR | M | Y | 76.20000 | KG | 20160930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121444535 | 12144453 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, 1X/DAY, AT NIGHT | 21938 | 37.5 | MG | CAPSULE, HARD | QD | ||||||
| 121444535 | 12144453 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (ONCE DAILY FOR 21 DAYS THEN 14 DAYS OFF) | 378CA | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 121444535 | 12144453 | 3 | C | OCTREOTIDE. | OCTREOTIDE | 1 | UNK UNK, MONTHLY, 20 OR 30 MG INJECTION | 0 | /month | ||||||||||
| 121444535 | 12144453 | 4 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 121444535 | 12144453 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, 1X/DAY, AT NIGHT | 0 | 10 | MG | QD | ||||||||
| 121444535 | 12144453 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
| 121444535 | 12144453 | 7 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0.4 MG, UNK | 0 | .4 | MG | |||||||||
| 121444535 | 12144453 | 8 | C | FISH OIL | FISH OIL | 1 | 1200 MG, UNK | 0 | 1200 | MG | |||||||||
| 121444535 | 12144453 | 9 | C | STOOL SOFTENER | DOCUSATE CALCIUM | 1 | 100 MG, 2X/DAY, ONE AND ONE AT NIGHT | 0 | 100 | MG | BID | ||||||||
| 121444535 | 12144453 | 10 | C | MAGNESIUM | MAGNESIUM | 1 | 250 MG, 1X/DAY, AT NIGHT | 0 | 250 | MG | QD | ||||||||
| 121444535 | 12144453 | 11 | C | BABY ASPIRIN | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
| 121444535 | 12144453 | 12 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 50 MG, 1X/DAY, AT NIGHT | 0 | 50 | MG | QD | ||||||||
| 121444535 | 12144453 | 13 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | 180 MG, 1X/DAY, IN THE MORNING | 0 | 180 | MG | QD | ||||||||
| 121444535 | 12144453 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | UNK, DAILY, 1000 EVERY DAY MOSTLY DURING THE WINTER, MAYBE ONCE OR TWICE A YEAR | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121444535 | 12144453 | 1 | Neuroendocrine tumour |
| 121444535 | 12144453 | 3 | Neuroendocrine tumour |
| 121444535 | 12144453 | 4 | Blood pressure abnormal |
| 121444535 | 12144453 | 5 | Blood cholesterol increased |
| 121444535 | 12144453 | 6 | Gout |
| 121444535 | 12144453 | 7 | Pollakiuria |
| 121444535 | 12144453 | 8 | Supplementation therapy |
| 121444535 | 12144453 | 10 | Hypertension |
| 121444535 | 12144453 | 11 | Prophylaxis |
| 121444535 | 12144453 | 12 | Sleep disorder |
| 121444535 | 12144453 | 13 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121444535 | 12144453 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121444535 | 12144453 | Blood potassium increased | |
| 121444535 | 12144453 | Blood pressure increased | |
| 121444535 | 12144453 | Diarrhoea | |
| 121444535 | 12144453 | Dry skin | |
| 121444535 | 12144453 | Dysgeusia | |
| 121444535 | 12144453 | Dyspnoea | |
| 121444535 | 12144453 | Fatigue | |
| 121444535 | 12144453 | Flatulence | |
| 121444535 | 12144453 | Gastrointestinal sounds abnormal | |
| 121444535 | 12144453 | Haemorrhoids | |
| 121444535 | 12144453 | Incorrect product storage | |
| 121444535 | 12144453 | Lacrimation increased | |
| 121444535 | 12144453 | Nasal congestion | |
| 121444535 | 12144453 | Pain in extremity | |
| 121444535 | 12144453 | Poor quality drug administered | |
| 121444535 | 12144453 | Product use issue | |
| 121444535 | 12144453 | Rhinorrhoea | |
| 121444535 | 12144453 | Thyroid disorder | |
| 121444535 | 12144453 | Vitamin D decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121444535 | 12144453 | 1 | 20150813 | 0 | ||
| 121444535 | 12144453 | 2 | 201508 | 0 | ||
| 121444535 | 12144453 | 3 | 201101 | 0 |